Rho-ROCK signaling is involved with migration, controlling the organization of actin cytoskeleton and cell motility by activating a number of downstream targets [60], while this increased FAK expression and decreased Src expression contributes to the tumor cells being able to bind to the bone ECM and establish in the bone microenvironment. The gene discussed is RHO; the disease is neoplasm.